Related Experiment Video
Updated: Aug 23, 2025

Assessing Specificity of Anticancer Drugs In Vitro
Published on: March 23, 2016
[Assessment of new oncological drugs]
1Nederlandse Vereniging voor Medische Oncologie, Utrecht.
Abstract:
As the number of cancer patients increases and new (mostly expensive) treatment options are evolving rapidly, a critical evaluation of the value of new treatments is required in order to maintain access to new drugs and affordable cancer care. In the Netherlands, the Dutch Society of Medical Oncology- CieBOM (NVMO CieBOM) has an unique role in assessment of the value and use of new oncological drugs, next to the National Committee of Health Insurance (cieBAG) and the Dutch Health Care Institute. CieBOM developed transparent criteria for approval of oncological drugs in several settings, and recently also criteria for drugs only tested in non-randomised studies have been developed.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Clinical Trials: Overview
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Treatment Resistant Cancers
Cancer Survival Analysis

